Who will take informed consent? {26a}
ISCHEMIC STROKE
Patients will be checked for eligibility by a study physician after admission due to acute ischemic stroke. Study inclusion is possible from the day of admission. Each eligible patient will be informed about the modalities of the clinical investigation in accordance with the provided patient informed consent (IC). The patient is to be informed both in writing and verbally by the investigator before any study‐specific procedure is performed. The patient will be given sufficient time (i.e., > 24 h) to decide whether to participate in this study and to ask questions concerning this trial. The patient must give consent in writing. The patient and informing physician must each personally date and sign the informed consent form with an integrated declaration on data privacy protection.